![Gelofusine Attenuates Tubulointerstitial Injury Induced by cRGD-Conjugated siRNA by Regulating the TLR3 Signaling Pathway: Molecular Therapy - Nucleic Acids Gelofusine Attenuates Tubulointerstitial Injury Induced by cRGD-Conjugated siRNA by Regulating the TLR3 Signaling Pathway: Molecular Therapy - Nucleic Acids](https://www.cell.com/cms/attachment/13f1577d-4795-4b45-8f0a-7da612c9a9dd/gr4_lrg.jpg)
Gelofusine Attenuates Tubulointerstitial Injury Induced by cRGD-Conjugated siRNA by Regulating the TLR3 Signaling Pathway: Molecular Therapy - Nucleic Acids
![Effects of an intraoperative infusion of 4% succinylated gelatine ( Gelofusine®) and 6% hydroxyethyl starch (Voluven®) on blood volume - ScienceDirect Effects of an intraoperative infusion of 4% succinylated gelatine ( Gelofusine®) and 6% hydroxyethyl starch (Voluven®) on blood volume - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0007091217328854-gr4.jpg)
Effects of an intraoperative infusion of 4% succinylated gelatine ( Gelofusine®) and 6% hydroxyethyl starch (Voluven®) on blood volume - ScienceDirect
![99mTc‑labeled single-domain antibody for SPECT/CT assessment of HER2 expression in diverse cancer types | European Journal of Nuclear Medicine and Molecular Imaging 99mTc‑labeled single-domain antibody for SPECT/CT assessment of HER2 expression in diverse cancer types | European Journal of Nuclear Medicine and Molecular Imaging](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00259-022-06066-3/MediaObjects/259_2022_6066_Fig3_HTML.png)
99mTc‑labeled single-domain antibody for SPECT/CT assessment of HER2 expression in diverse cancer types | European Journal of Nuclear Medicine and Molecular Imaging
![PDF) Effect of volume loading with 1 liter intravenous infusions of 0.9% saline, 4% succinylated gelatine (Gelofusine) and 6% hydroxyethyl starch (Voluven) on blood volume and endocrine responses: A randomized, three-way crossover PDF) Effect of volume loading with 1 liter intravenous infusions of 0.9% saline, 4% succinylated gelatine (Gelofusine) and 6% hydroxyethyl starch (Voluven) on blood volume and endocrine responses: A randomized, three-way crossover](https://0.academia-photos.com/attachment_thumbnails/43622260/mini_magick20180819-23437-18wodrq.png?1534708683)
PDF) Effect of volume loading with 1 liter intravenous infusions of 0.9% saline, 4% succinylated gelatine (Gelofusine) and 6% hydroxyethyl starch (Voluven) on blood volume and endocrine responses: A randomized, three-way crossover
![Effects of an intraoperative infusion of 4% succinylated gelatine ( Gelofusine®) and 6% hydroxyethyl starch (Voluven®) on blood volume† - British Journal of Anaesthesia Effects of an intraoperative infusion of 4% succinylated gelatine ( Gelofusine®) and 6% hydroxyethyl starch (Voluven®) on blood volume† - British Journal of Anaesthesia](https://www.bjanaesthesia.org.uk/cms/attachment/6a168052-f67a-4fc0-b816-e97ed59cff71/gr2_lrg.jpg)
Effects of an intraoperative infusion of 4% succinylated gelatine ( Gelofusine®) and 6% hydroxyethyl starch (Voluven®) on blood volume† - British Journal of Anaesthesia
![Renal Uptake of Radiolabeled Octreotide in Human Subjects Is Efficiently Inhibited by Succinylated Gelatin | Journal of Nuclear Medicine Renal Uptake of Radiolabeled Octreotide in Human Subjects Is Efficiently Inhibited by Succinylated Gelatin | Journal of Nuclear Medicine](https://jnm.snmjournals.org/content/jnumed/47/3/432/F1.large.jpg)
Renal Uptake of Radiolabeled Octreotide in Human Subjects Is Efficiently Inhibited by Succinylated Gelatin | Journal of Nuclear Medicine
![Renal Uptake of Radiolabeled Octreotide in Human Subjects Is Efficiently Inhibited by Succinylated Gelatin | Journal of Nuclear Medicine Renal Uptake of Radiolabeled Octreotide in Human Subjects Is Efficiently Inhibited by Succinylated Gelatin | Journal of Nuclear Medicine](https://jnm.snmjournals.org/content/jnumed/47/3/432/F4.large.jpg)
Renal Uptake of Radiolabeled Octreotide in Human Subjects Is Efficiently Inhibited by Succinylated Gelatin | Journal of Nuclear Medicine
![Gelofusine® – A colloidal volume replacement fluid based on 4 % modified fluid gelatin – GHA – German Health Alliance Gelofusine® – A colloidal volume replacement fluid based on 4 % modified fluid gelatin – GHA – German Health Alliance](https://gha.health/wp-content/uploads/2020/02/hires1-1890.jpg)
Gelofusine® – A colloidal volume replacement fluid based on 4 % modified fluid gelatin – GHA – German Health Alliance
![IJMS | Free Full-Text | Priming of Cardiopulmonary Bypass with Human Albumin Decreases Endothelial Dysfunction after Pulmonary Ischemia–Reperfusion in an Animal Model IJMS | Free Full-Text | Priming of Cardiopulmonary Bypass with Human Albumin Decreases Endothelial Dysfunction after Pulmonary Ischemia–Reperfusion in an Animal Model](https://pub.mdpi-res.com/ijms/ijms-23-08938/article_deploy/html/images/ijms-23-08938-g006.png?1660204430)
IJMS | Free Full-Text | Priming of Cardiopulmonary Bypass with Human Albumin Decreases Endothelial Dysfunction after Pulmonary Ischemia–Reperfusion in an Animal Model
![Effects of an intraoperative infusion of 4% succinylated gelatine ( Gelofusine®) and 6% hydroxyethyl starch (Voluven®) on blood volume† - British Journal of Anaesthesia Effects of an intraoperative infusion of 4% succinylated gelatine ( Gelofusine®) and 6% hydroxyethyl starch (Voluven®) on blood volume† - British Journal of Anaesthesia](https://www.bjanaesthesia.org.uk/cms/attachment/6e248c1f-0b46-4c38-adfd-b2b83c3b07de/gr1_lrg.jpg)